Prenetics Global Limited (NASDAQ:PRENW) Sees Significant Decline in Short Interest

Prenetics Global Limited (NASDAQ:PRENW) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totaling 6,074 shares, a decrease of 61.8% from the September 15th total of 15,897 shares. Based on an average daily trading volume, of 76,867 shares, the short-interest ratio is currently 0.1 days.

Prenetics Global Stock Performance

Shares of Prenetics Global stock remained flat at $0.01 during trading hours on Wednesday. 12,144 shares of the company’s stock were exchanged, compared to its average volume of 44,198. Prenetics Global has a 12-month low of $0.01 and a 12-month high of $0.04. The business has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.

About Prenetics Global

Prenetics Global Limited is a Hong Kong-based health sciences company focused on genomics, precision oncology and early cancer detection. Founded in 2014 by Danny Yeung, the company develops and commercializes genetic testing and health-information products intended to support preventive care, personalized wellness and clinical decision-making.

Its consumer health business includes CircleDNA, a direct-to-consumer genetic testing platform that provides reports related to ancestry, wellness, nutrition, fitness and disease risk.